Dateline: LONDON, July 1, 2025 – AstraZeneca CEO Pascal Soriot is considering moving the company’s stock market listing to the U.S., motivated by U.K. regulatory constraints. AstraZeneca may shift its listing from London to the U.S. Regulatory restrictions in the U.K. influence the decision. CEO...